Skip to main content
. Author manuscript; available in PMC: 2017 May 11.
Published in final edited form as: Leukemia. 2016 Oct 31;31(5):1059–1068. doi: 10.1038/leu.2016.309

Figure 4.

Figure 4

Effect of CD33 expression levels on (A) relapse, (B) overall survival and (C) early mortality (60 days) in patients randomised to receive 6mg/m2 or 3mg/m2 GO dose

Forest plot analysis of 464 younger patients (NCRI-AML17 trial) assessable for GO vs no GO comparison. Patients were stratified into CD33 expression quartile using CD33-MFI and %CD33-positivity.